Medical Perfusion Technology Market is expected to reach US$ 962.60 Mn by 2027

By Technique, Normothermic Machine Perfusion Segment to Grow at Higher CAGR During 2020–2027

According to our new research study on “Medical Perfusion Technology Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Technique, Organ Type, and Component,” the market is expected to reach US$ 962.60 million by 2027 from US$ 707.10 million in 2019. The market is estimated to grow at a CAGR of 4.1% from 2020 to 2027. Factors such as rise in prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, increase in need for organ transplantation, and rise in cell-based research activities play a vital role in the growth of the medical perfusion technology market. However, the challenges such as expensive organ transplant surgeries and limited numbers of donors for organ transplant surgeries are likely to impact the growth of the market during the forecast period. On the other hand, technological developments in the emerging nations are likely to provide a significant opportunity for the market growth in the coming years.

Based on technique, the medical perfusion technology market is segmented into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment held larger share of the market in 2019. However, the normothermic machine perfusion segment is estimated to register higher CAGR of 4.4% in the market during the forecast period.

Getinge AB, Medtronic, LivaNova PLC, Terumo Corporation, XVIVO Perfusion, OrganOx Limited, Waters Medical Systems LLC, TransMedics, Organ Recovery Systems, and Xenios AG – a Fresenius Medical Care are among the leading companies operating in the medical perfusion technology market. The companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio to meet the rising demands for the medical perfusion technology. For instance, in May 2019, Terumo Cardiovascular Group, a world pioneer in cardiovascular surgery technology, and Talis Clinical, a major supplier of healthcare software solutions, have announced the commercial availability of ACG-Perfusion and ACG-RemoteView Systems in North America.

Medical Perfusion Technology Market, by Region, 2019 (%)

The report segments global medical perfusion technology market as follows:

By Software Type

• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion

By Organ Type

• Heart
• Lung
• Kidney
• Liver
• Others

By Component

• Perfusion Pumps
• Oxygenators
• Heart-Lung Machines
• Monitoring Systems
• Cannulas
• Others

By Geography

• North America
  • • US
    • Canada
    • Mexico
• Europe
  • • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
• Asia Pacific (APAC)
  • • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of APAC
• Middle East & Africa (MEA)
  • • Saudi Arabia
    • UAE
    • South Africa
    • Rest of MEA
• South and Central America (SCAM)
  • • Brazil
    • Argentina
    • Rest of SCAM